ORGANIZATION

• PhRMA Wants No Off-Year Price Cuts, Urges Japan Not to Backslide: Chair
  November 28, 2024

• JGA to Launch Study Group on Industry Revamp by End of FY2024
  November 26, 2024

• Japan Pharmacy Group Demands Abolishing Off-Year Price Revisions
  November 22, 2024

• Chuikyo Payer Rep Touts Necessity of FY2025 Off-Year Price Revision
  November 19, 2024

• Japan, US, Europe Trade Groups Urge Ishiba Govt to Scrap Off-Year Revisions
  November 18, 2024

• JPMA Appreciates Growing Calls for Abolition of Off-Year Revisions: Exec
  November 15, 2024

• Osaka’s New Life Science Hub to Grow into Full Ecosystem in 5 Years: Operator
  November 12, 2024

• Self-Medication and Proper Drug Pricing 2 Sides of the Same Coin: Professor
  November 8, 2024

• Japan Wholesaler Group to Continue Stressing Plight of Supply Disruption
  October 25, 2024

• Drug Therapy for Fetal Tachyarrhythmia Gets 1st Health Coverage in Japan
  October 21, 2024

• Off-Year Price Revision Has Accomplished Mission: JPMA Exec
  October 18, 2024

• JaDHA Inks MOU with DTA to Collaborate in DTx Push
  October 16, 2024

• JaDHA Creates Hypothetical Case Collection to Push Two-Stage Approval of SaMD
  October 11, 2024

• EFPIA Chief Sees Positive Signal from Japan Policymakers, Calls for Consistency
  October 11, 2024

• EFPIA Japan Chair Urges All Players to Join Forces in Drug Loss Fight
  October 10, 2024

• New Administration Must Not Stop Efforts toward Bolstering Pharma Industry: JPMA Chief
  October 9, 2024

• Pharma Labor Group Renews Call for Abolition of Off-year Revisions
  October 9, 2024

• Policy Veterans’ Group Proposes Special Drug Price Rule for Antibiotics
  October 3, 2024

• Japan Generic Use Rate Reaches 83.5% in April-June: JGA
  September 30, 2024

• Japan Wholesalers Enjoy Growth as COVID Meds Enter Commercial Route
  September 27, 2024

ページ

• « 先頭
• ‹ Prev
• …
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• …
• Next ›
• 最終 »